COVID-19 impairs oxygen delivery by altering red blood cell hematological, hemorheological, and oxygen transport properties, 2024, Stephen C. Rogers

Mij

Senior Member (Voting Rights)
Introduction: Coronavirus disease 2019 (COVID-19) is characterized by impaired oxygen (O2) homeostasis, including O2 sensing, uptake, transport/delivery, and consumption. Red blood cells (RBCs) are central to maintaining O2 homeostasis and undergo direct exposure to coronavirus in vivo. We thus hypothesized that COVID-19 alters RBC properties relevant to O2 homeostasis, including the hematological profile, Hb O2 transport characteristics, rheology, and the hypoxic vasodilatory (HVD) reflex.

Methods: RBCs from 18 hospitalized COVID-19 subjects and 20 healthy controls were analyzed as follows: (i) clinical hematological parameters (complete blood count; hematology analyzer); (ii) O2 dissociation curves (p50, Hill number, and Bohr plot; Hemox-Analyzer); (iii) rheological properties (osmotic fragility, deformability, and aggregation; laser-assisted optical rotational cell analyzer (LORRCA) ektacytometry); and (iv) vasoactivity (the RBC HVD; vascular ring bioassay).

Results: Compared to age- and gender-matched healthy controls, COVID-19 subjects demonstrated 1) significant hematological differences (increased WBC count—with a higher percentage of neutrophils); RBC distribution width (RDW); and reduced hematocrit (HCT), Hb concentration, mean corpuscular volume (MCV), and mean corpuscular hemoglobin concentration (MCHC); 2) impaired O2-carrying capacity and O2 capacitance (resulting from anemia) without difference in p50 or Hb–O2 cooperativity; 3) compromised regulation of RBC volume (altered osmotic fragility); 4) reduced RBC deformability; 5) accelerated RBC aggregation kinetics; and (6) no change in the RBC HVD reflex.

Discussion: When considered collectively, homeostatic compensation for these RBC impairments requires that the cardiac output in the COVID cohort would need to increase by ∼135% to maintain O2 delivery similar to that in the control cohort. Additionally, the COVID-19 disease RBC properties were found to be exaggerated in blood-type O hospitalized COVID-19 subjects compared to blood-type A. These data indicate that altered RBC features in hospitalized COVID-19 subjects burden the cardiovascular system to maintain O2 delivery homeostasis, which appears exaggerated by blood type (more pronounced with blood-type O) and likely plays a role in disease pathogenesis.

https://www.frontiersin.org/articles/10.3389/fphys.2023.1320697/full
 
likely plays a role in disease pathogenesis.
I think it's a bit early to be making that claim. 18 subjects vs 20 healthy controls is small and doesn't rule out similar effects from other immune-activating diseases. Interesting, but it needs a larger study with some unhealthy controls.
 
including O2 sensing
Something I hadn't seen for a while, but it has never been explained why COVID makes some people highly hypoxic, to a point far below the usual "danger" level, without any explanation. What was called "happy hypoxia" in the early days, which, wow, Orwell would be really weirded out by. I don't know if that's still happening, O2% is barely mentioned anymore, even in the LC community.

Given that it's an objective sign, one would have thought that it would be of some great interest. And yet, nope.
 
Back
Top Bottom